MAPT and Alzheimer disease: Differences include the absence of phosphorylation and acetylation at the N-terminal in DLBTau+ patients, reduced phosphorylation sites at the C-terminal, and the identification of one site of phosphorylation at S324, not found on AD tau in that study (Fig. 6b).